Sfoglia per AUTORE
BONI C
Collezione AO Cuneo

  

Items : 5

Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2?×?2 factorial, randomised phase 3 trial. in Lancet (London, England) / Lancet. 2015 May 9;385(9980):1863-72. doi: 10.1016/S0140-6736(14)62048-1. Epub 2015 Mar 2.

2015
AO Cuneo

Cognetti F; Forestieri V; Bisagni G; Bighin C; Papaldo P; Gravina A; Gamucci T; Giuliano M; Colantuoni G; Ardizzoni A; Barni S; Montemurro F; Puglisi F; Garrone O; Valle E; Durando A; Nisticò C; Turletti A; Cavazzini G; Boni C; De Placido S; De Laurentiis M; Bruzzi P; Del Mastro L;

Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Apr;26(4):724-730. doi: 10.1093/annonc/mdv012. Epub 2015 Jan 18.

2015
AO Cuneo

Falcone A; Amoroso D; Bonetti A; Chiara S; Allegrini G; Boni C; Fea E; Antonuzzo L; Granetto C; Barbara C; Safina V; Cupini S; Schirripa M; Cremolini C; Fornaro L; Boni L; Masi G; Loupakis F; Salvatore L;

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer in Annals of Oncology

2014
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 2

Bajetta E; Floriani I; Di Bartolomeo M; Labianca R; Falcone A; Di Costanzo F; Comella G; Amadori D; Pinto C; Carlomagno C; Nitti D; Daniele B; Mini E; Poli D; Santoro A; Mosconi S; Casaretti R; Boni C; Pinotti G; Bidoli P; Landi L; Rosati G; Ravaioli A; Cantore M; Di Fabio F; Aitini E; Marchet A; Rulli E; Cropalato Di Tullio M; et alii...

Subgroup analyses in RAS mutant, BRAF mutant and all-wt mCRC pts treated with FOLFOXIRI plus bevacizumab (bev) or FOLFIRI plus bev in the TRIBE study in Journal of Clinical Oncology

2014
AO Cuneo

Loupakis F; Cremolini C; Lonardi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Valsuani C; Chiara S; Boni C; Marcucci L; Negri F; Barone C; Vitello S; D'Amico M; Granetto C; Fontanini G; Tomcikova D; Boni L; Falcone A;

Second-line chemotherapy (CT) with or without bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts) who progressed to a first-line treatment containing BV: Updated results of the phase III “BEBYP” trial by the Gruppo Oncologico Nord Ovest (GONO) in Journal of Clinical Oncology

2013
AO Cuneo

Masi G; Loupakis F; Salvatore L; Cremolini C; Fornaro L; Schirripa M; Granetto C; Miraglio E; Di Costanzo F; Antonuzzo L; Marcucci L; Barbara C; Boni C; Banzi M; Chiara S; Garbarino D; Valsuani C; Bonetti A; Boni L; Falcone A;